Zolpidem Use and Depression Risk

Introduction to Zolpidem and Depression

The American College of Physicians recommends that zolpidem should only be used for short-term treatment of insomnia (≤4 weeks) to minimize risk of dependency and adverse effects, including depression 1
Approximately 50% of patients prescribed Z-drugs, including zolpidem, have been treated continuously for at least 12 months, despite recommendations against long-term use 2, 1

The American Academy of Sleep Medicine suggests that cognitive behavioral therapy for insomnia (CBT-I) is more effective than pharmacotherapy long-term, and should be used as first-line treatment for patients with depression and insomnia 3, 4
The FDA approved zolpidem for short-term use (4-5 weeks), and patients should not continue using the drug for extended periods, with a recommendation to discontinue using gradual tapering to minimize withdrawal symptoms if already prescribed 3, 1

For patients on long-term zolpidem who develop depression, the National Institute of Mental Health recommends recognizing this as a potential adverse drug effect, initiating tapering and discontinuation, and implementing CBT-I as replacement therapy 1, 3, 4